Repositorio Dspace

Development of a proficiency testing platform for advanced therapies medicinal products (ATMPs)

Mostrar el registro sencillo del ítem

dc.contributor.author Chaparro-García, Jesús
dc.contributor.author Maldonado-Sánchez, Rafael
dc.contributor.author Moisan, Anaick
dc.contributor.author Blanco, Marga
dc.contributor.author Antúnez, Cristina
dc.contributor.author Guerrero, Jorge
dc.contributor.author Fernández, Natividad
dc.contributor.author Eisman, Marcela
dc.contributor.author Tristante-Barrenechea, Elena
dc.contributor.author Martínez-Lorenzo, María-José
dc.contributor.author Vuelta, Elena
dc.contributor.author Calvo, Javier
dc.contributor.author Catalina, Purificación
dc.contributor.author Moreno-Pantoja, Alicia
dc.contributor.author Santos-González, Mónica
dc.contributor.author Bermejo, María
dc.contributor.author Arribas-Arribas, Blanca
dc.contributor.author Leyva, Laura
dc.contributor.author Rodríguez-Acosta, Antonio
dc.date.accessioned 2026-08-03T10:26:58Z
dc.date.available 2026-08-03T10:26:58Z
dc.date.issued 2026-06
dc.identifier.issn 1465-3249
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/27162
dc.description.abstract BACKGROUND: The development of Advanced Therapy Medicinal Products (ATMPs) is driving major advances in regenerative medicine, particularly in cellular immunotherapies. However, the reliable application of quality control methods remains a major challenge due to the inherent complexity of biotechnological products, especially when assays involve living cells. In this context, Proficiency Testing (PT) programs have proven to be highly effective tools for promoting analytical consistency and enhancing quality across laboratories in a wide range of application fields. This study presents the design and implementation of a PT program specifically adapted to ATMPs. The initiative was publicly funded by Andalusian Regional Government (Spain) and involved ATMP manufacturers, Tissue Establishments, and a Biobank from Spain and France. METHODS: Thirteen public ATMPs manufacturers, Tissue Establishments and one Biobank from Spain and France participated in the program. A dedicated web platform was developed to manage participant interactions and data submission, with the primary objective of ensuring anonymization of participants and their results. Standardized samples were simultaneously distributed to all sites to ensure consistency across assays. These included materials for mycoplasma detection, sterility testing, endotoxin quantification, immunophenotyping, cell counting, thawing yield, and growth promotion (cell doublings). At the end of each round, participants received an automated, personalized report benchmarking their performance against peer laboratories. RESULTS: Across five rounds of proficiency testing involving 13 institutions, 331 valid results were reported from 372 distributed samples (88.9% response rate). Mycoplasma detection showed 77.8% sensitivity and 100% specificity. Sterility testing achieved 97% sensitivity and 100% specificity. Endotoxin assays yielded 100% accuracy across all samples. Immunophenotyping confirmed >95% expression of MSC markers, with minimal hematopoietic contamination. Moderate variability was observed in cell count results, with 57.1% aligning within ±20% of the median reference value. Growth promotion studies revealed superior cell doublings and shorter doublings times with human platelet lysate compared to fetal bovine serum. Thawing yield averaged 41.5%, with similar recovery between manual and automated methods. Satisfaction surveys indicated high approval for sample quality and identification, with constructive feedback on logistics and platform usability. Most participants supported program continuity through financial contribution. CONCLUSIONS: This multicenter initiative highlights the value of interlaboratory comparisons for harmonizing ATMP methodologies. While sterility and endotoxin assays showed high consistency, cell-based techniques remain variable and need further standardization.
dc.language.iso eng
dc.publisher ELSEVIER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Laboratory Proficiency Testing/methods
dc.subject.mesh Quality Control
dc.subject.mesh Regenerative Medicine/standards/methods
dc.subject.mesh France
dc.subject.mesh Spain
dc.subject.mesh Cell- and Tissue-Based Therapy
dc.title Development of a proficiency testing platform for advanced therapies medicinal products (ATMPs)
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 41932045
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S1465324926000848
dc.type.version info:eu-repo/semantics/publishedVersion 
dc.identifier.doi 10.1016/j.jcyt.2026.102122
dc.journal.title CYTOTHERAPY
dc.identifier.essn 1477-2566


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta